Benzinga | Aug 2, 2021 07:10AM EDT

TG Therapeutics Q2 EPS $(0.59) Misses $(0.50) Estimate, Sales $1.54M Up From $38.00K YoY

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.50) by 18 percent. This is a 25.53 percent decrease over losses of $(0.47) per share from the same period last year. The company reported $1.54 million in sales this quarter. This is a 3.97K percent increase over sales of $38.00 thousand the same period last year.